版本:
中国

BRIEF-Zafgen preclinical abstract will present results for zgn-1061 on glycemic control, weight loss and safety profile

June 6 Zafgen Inc:

* Zafgen to present two late-breaking abstracts for zgn-1061 at the american diabetes association 77th scientific sessions

* Preclinical abstract will present results for zgn-1061 on glycemic control, weight loss and safety profile

* Clinical abstract will provide full data set from zgn-1061 phase 1 clinical trial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐